PhRMA Wants Clearer Definition Of Safety “Signal”; FDA Proposes Newsletter

FDA's upcoming pharmacovigilance guidance should include a clearer definition of what constitutes a drug risk "signal," the Pharmaceutical Research & Manufacturers of America maintains